SUMMIT THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 08 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98489112
- Mark type
- Design + words
- Filed
- 08 Apr 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Andrea M. Porterfield
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology
Owner
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
Prosecution history
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 2 GRANTED
- 02 Mar 2026 — SOU EXTENSION 2 FILED
- 02 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — CORRECTED NOA E-MAILED
- 26 Jan 2026 — SOU EXTENSION 1 GRANTED
- 27 Aug 2025 — SOU EXTENSION 1 FILED
- 26 Jan 2026 — DIVISIONAL PROCESSING COMPLETE
- 07 May 2025 — DIVISIONAL REQUEST RECEIVED
- 16 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 07 May 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED